Ann: Further Analysis of Phase 2 PTSD Trial Results Presentation, page-15

This is not a sub-group analysis like the one for BNC105. BNC105 went nowhere because sub-group analysis are usually ignored by FDA.

I am skeptical even with this 'great' news. Why was it kept a secret .. well secret for peons anyway?

Will FDA buy it? Let us say they do. How much dilution of Bionomics share price to conduct one more phase 2 trial? Can they sell the company for say 50 cents a share? Just 100 million dollars and the buyer has a potential gold mine. 

The board of BNO has a fiduciary responsibility to actively find suitors. I hope they see the writing on the wall.